TP53 Mutational Status and Cetuximab Benefit in Rectal CancerTP53 Mutational Status and Cetuximab Benefit in Rectal Cancer

Get the latest on locally advanced rectal cancer treatment from this updated analysis of the EXPERT-C trial. Journal of the National Cancer Institute
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news